stockrow
Friday 6 November 2026
Export MBX’s income statement to Excel — free account
MBX Biosciences, Inc.
- EPS
- −34.5%
- Free cash flow
- −29.7%
Quarter to June 2026, against a year earlier
50.89
2.43
+5.01%
Follow MBX
Alert me
MBX Biosciences, Inc. (MBX) Book value per share
MBX Biosciences, Inc.'s book value per share at the end of fiscal 2025 was 10.1×, down 58.2% from 24.2× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 8.6×. MBX Biosciences, Inc. ranks 89th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 10.1× | (58.19%) |
| FY2024 | 24.2× | — |
| FY2023 | −71.1× | — |
| FY2022 | −63.9× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 8.6× | (8.64%) |
| Mar 2026 | 9.4× | (7.07%) |
| Dec 2025 | 10.1× | (10.75%) |
| Sep 2025 | 11.3× | 72.87% |
| 8 more quarters | Free account |
Book value per share against peers
| Company | Book value per share |
|---|---|
| CLDX Celldex Therapeutics, Inc. compare | 9.2× |
| MBX MBX Biosciences, Inc. | 8.6× |
| XNCR Xencor, Inc. compare | 6.6× |
| PHVS Pharvaris N.V. compare | 5.1× |
| NAMS NewAmsterdam Pharma Company N.V. compare | 5.1× |
| RCUS Arcus Biosciences, Inc. compare | 2.8× |
| ADMA ADMA Biologics Inc compare | 2.0× |
| RXRX Recursion Pharmaceuticals, Inc. compare | 1.7× |
| ZLAB Zai Lab Limited Unsponsored ADR compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))